Eagle Rock Investment Company LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 71.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,121 shares of the company's stock after buying an additional 25,936 shares during the quarter. Eagle Rock Investment Company LLC's holdings in GE HealthCare Technologies were worth $4,857,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of GEHC. Mesirow Financial Investment Management Inc. grew its position in GE HealthCare Technologies by 39.6% during the third quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock worth $383,000 after buying an additional 1,159 shares in the last quarter. LMR Partners LLP bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at about $7,387,000. Principal Financial Group Inc. grew its holdings in shares of GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock worth $94,780,000 after purchasing an additional 19,010 shares in the last quarter. Everence Capital Management Inc. increased its position in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company's stock worth $1,475,000 after purchasing an additional 10,220 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in GE HealthCare Technologies in the third quarter valued at approximately $1,396,000. 82.06% of the stock is currently owned by institutional investors.
GEHC has been the subject of a number of research reports. Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and cut their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a report on Monday, September 30th. Finally, Evercore ISI raised their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $96.00.
Read Our Latest Research Report on GE HealthCare Technologies
Shares of GEHC stock opened at $85.00 on Friday. The company has a market capitalization of $38.83 billion, a P/E ratio of 23.35, a PEG ratio of 2.80 and a beta of 1.11. GE HealthCare Technologies Inc. has a fifty-two week low of $71.31 and a fifty-two week high of $94.55. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock has a 50 day moving average price of $82.07 and a two-hundred day moving average price of $84.26.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm's revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.99 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.30%.
In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is owned by company insiders.
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.